| Heading: |
Pancreatic Enzyme Replacement Therapy: Shortages |
| Question ID: |
1792329 |
| UIN: |
44155 |
| House: |
Commons |
| Date tabled: |
2025-04-03 |
| Asking Member ID: |
5157 |
| Asking Member display name: |
Susan Murray
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Susan Murray
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 March 2025 to Question 35462 on Pancreatic Enzyme Replacement Therapy shortages, what the (a) dates and (b) attendees were of meetings held with (i) clinicians, (ii) pat |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-09 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is in regular discussions with the suppliers of pancreatic enzyme replacement therapy on the latest stock availability and the actions being taken to mitigate the supply issue that is affecting the whole of the United Kingdom. We have had d... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |